Target intelligence / Profile preview

Intracellular proteins and organelles of granulocytes

Molecular classification
Other
01

Overview

Intracellular proteins and organelles of granulocytes refers to the complex internal machinery of white blood cells such as neutrophils, eosinophils, and basophils, which are characterized by the presence of specialized granules. These granules contain a variety of enzymes and antimicrobial proteins, including myeloperoxidase (MPO), proteinase 3 (PR3), and elastase, which are essential for the innate immune system's ability to neutralize pathogens (StatPearls, 2023). In the context of pathology, these intracellular components are frequently the targets of antineutrophil cytoplasmic antibodies (ANCA), leading to autoimmune disorders like granulomatosis with polyangiitis and microscopic polyangiitis (NIH, 2022). Therapeutic strategies often involve broad immunosuppression to reduce the production of these autoantibodies or, more recently, the development of specific inhibitors for individual enzymes like MPO to treat chronic inflammatory conditions (PubMed, 2021). Because this term encompasses a wide range of distinct molecular entities rather than a single receptor or enzyme, it is generally classified as a cellular compartment or a group of antigens rather than a specific drug target.

Other names
Neutrophil cytoplasmic antigensGranulocyte cytoplasmic proteinsGranulocyte granulesANCA antigens
02

Mechanism of action

Therapeutic intervention involves broad immunosuppression to inhibit the production of autoantibodies against these proteins, or the use of specific small-molecule inhibitors to block the enzymatic activity of individual components like myeloperoxidase.

03

Biological functions

Immune responseInflammationDegranulationPhagocytosisPathogen killing
04

Disease associations

VasculitisAutoimmune diseaseInflammationGranulomatosis with polyangiitisMicroscopic polyangiitis
05

Safety considerations

Increased risk of opportunistic infectionsBone marrow suppressionHepatotoxicityPotential for secondary malignancies
06

Interacting drugs

Rituximab

5 more in the full profile.

07

Biomarkers

Antineutrophil cytoplasmic antibodies (ANCA)Myeloperoxidase-ANCA (MPO-ANCA)Proteinase 3-ANCA (PR3-ANCA)

Beyond the preview

Go deeper on Intracellular proteins and organelles of granulocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular proteins and organelles of granulocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call